© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Understanding Chronic Hand Eczema: More Than Just Atopic Dermatitis
June 10, 2025
RAD 2025: Jiade Yu, MD, discussed chronic hand eczema as a distinct condition from AD, highlighting its clinical burden and emerging treatments, such as delgocitinib.
Arcutis Begins Study of Roflumilast Cream 0.05% in Infants with Atopic Dermatitis
June 10, 2025
Arcutis Biotherapeutics announced today the enrollment of the first patient in the phase 2 INTEGUMENT-INFANT trial.
George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults
June 10, 2025
The novel triple fixed-dose combination of telmisartan, amlodipine and indapamide, is the first of its kind approved for initial treatment of hypertension.
2025 ACOG Annual Clinical & Scientific Meeting: What You May Have Missed
June 10, 2025
From primary care management of heavy menstrual bleeding to postpartum depression screening, find out what you may have missed at ACOG 2025.
Clesrovimab Wins FDA Approval for Prevention of RSV LRTD in Infants During First RSV Season
June 10, 2025
The preventive monoclonal antibody is designed to protect infants against RSV infection through 5 months and is administered at the same dose, regardless of weight.
Q&A: Cumulative Life Course Impairment of Atopic Dermatitis with Mona Shahriari, MD
June 10, 2025
Clinicians learn to recognize the hidden psychosocial burdens of atopic dermatitis, emphasizing comprehensive care beyond skin symptoms for better patient outcomes.
Chronic Hand Eczema: Clinical Insights and Future Directions from RAD 2025
June 10, 2025
RAD 2025: Explore expert insights on chronic hand eczema, its differences from atopic dermatitis, and emerging treatments in this informative video series.
Upadacitinib Shows Real-World Efficacy in Bio-Naïve, Bio-Experienced Adults with Atopic Dermatitis in New Study
June 09, 2025
RAD 2025: Many adults achieved optimal treatment targets with upadacitinib after 6 months, regardless of prior biologic therapy, according to new late-breaking data.
Q&A: Managing Chronic Itch With Renowned Investigator Gil Yosipovitch, MD
June 09, 2025
RAD 2025: World expert on the pathophysiology of itch Gil Yosipovitch, MD, answers questions on the disease of chronic itch and on the expanding options for targeted treatment.
Beyond the Rash: Collaborative Insights on Pediatric Atopic Dermatitis
June 09, 2025
RAD 2025: Lisa Swanson, MD, shares insights on pediatric atopic dermatitis, addressing questions from both a dermatologist's and an allergist's perspective.